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It is estimated that a substantial proportion (30 - 50%) of fetal deaths 
are attributable to fetal growth restriction (FGR).[1] Approximately 
25% of children born in low- and-middle-income countries (LMICs) 
are small for gestational age (SGA).[2] Babies who are SGA are at 
increased risk of mortality and neonatal morbidity.[3,4] The SGA fetus 
may be small but healthy, or the condition may be due to pathological 
growth failure, i.e. FGR.[5] Some babies classified as appropriate for 
gestational age (AGA) may also be growth restricted, and a test to 
detect placental insufficiency would detect these fetuses as well[1] 
and be preferable to measuring size alone. In South Africa (SA), 
the largest category of perinatal deaths is unexplained stillbirths. A 
quarter of these fetuses are SGA, two-thirds of the deaths occur in the 
antenatal period, and most of the mothers are healthy and classified 
as having low-risk pregnancies.[6] 
The use of Doppler ultrasound for assessment of blood flow in 
fetal umbilical vessels can quantify placental function and be used 
to identify placental insufficiency in both SGA and AGA fetuses. 
Abnormal flow indices correlate with intrauterine growth retardation 
and adverse fetal and neonatal outcomes, particularly when absent or 
reversed end-diastolic flow is identified. Cochrane reviews on the use 
of Doppler ultrasound in high-risk pregnancies[7] indicate that it can 
reduce perinatal mortality and optimise the application of obstetric 
interventions. However, there have been only five trials in low-risk or 
unselected pregnancies.[8] There is insufficient evidence to establish 
whether use of Doppler ultrasound has benefits in these populations, 
and no trials have been conducted in unselected populations of 
women in LMICs. 
Objectives
To ascertain the prevalence of raised resistance indices (RIs) of the 
umbilical artery in a low-risk, low-income population and whether 
use of this information can prevent perinatal deaths.
Methods
A descriptive study investigated the prevalence of abnormal RIs 
and absent end-diastolic flow (AEDF) of the umbilical artery 
detected by the Umbiflow apparatus (Council for Scientific and 
Industrial Research (CSIR), SA), a hand-held, mobile continuous-
wave Doppler ultrasound device, in a low-risk and low-income 
pregnant population, and a cohort analytical study examined the 
This open-access article is distributed under 
Creative Commons licence CC-BY-NC 4.0.
Screening and managing a low-risk pregnant population 
using continuous-wave Doppler ultrasound in a low-
income population: A cohort analytical study
S Nkosi, FCOG (SA), MMed; J Makin, MB BCh, BSc (Epidemiology), MSc (Clinical Epidemiology); T Hlongwane, FCOG (SA), 
MMed (Obstetrics and Gynaecology); R C Pattinson, FRCOG, MD, FCOG (SA), MMed (Obstetrics and Gynaecology), MB BCh, BSc
South African Medical Research Council Maternal and Infant Health Care Strategies Unit, Faculty of Health Sciences, University of Pretoria,  
South Africa 
Corresponding author: S Nkosi (spencernkosi@gmail.com)
Background. In South Africa (SA), the largest category of perinatal deaths is unexplained stillbirths. Two-thirds of these occur in the 
antenatal period and most fetuses are macerated, but at antenatal clinics the mothers were generally regarded as healthy, with low-risk 
pregnancies. Innovative methods are urgently required to detect fetuses at risk of stillbirth and manage the mothers appropriately.
Objectives. To determine the prevalence of raised resistance indices (RIs) of the umbilical artery in a low-risk, low-income population and 
ascertain whether use of this information can prevent perinatal deaths.
Methods. A descriptive study was performed in Mamelodi township, east of Pretoria, SA, on pregnant women attending antenatal clinics 
draining to two community health centres (CHCs). These women, classified as having low-risk pregnancies, were screened for placental 
insufficiency using a continuous-wave Doppler ultrasound apparatus (Umbiflow) between 28 and 32 weeks’ gestation. When a raised RI was 
detected, the mother was referred to a high-risk clinic and managed according to a standard protocol. A cohort analytical study compared 
women who attended antenatal care at the same clinics as the Umbiflow group but did not have an Umbiflow test with those who had an 
Umbiflow test. The outcomes of all the deliveries in Mamelodi were recorded. The prevalences of abnormal RIs, absent end-diastolic flow 
(AEDF), stillbirths and neonatal deaths were the main outcome measures.
Results. An Umbiflow RI was performed in 2 868 women, and pregnancy outcome was available for 2 539 fetuses (88.5%); 297 fetuses 
(11.7%) were regarded as at high risk. AEDF was found in 1.5% of the population screened with an outcome. There were 29 perinatal 
deaths in the Umbiflow group (low risk n=18, high risk n=11). The perinatal mortality rate for 12 168 women attending the CHCs and the 
antenatal clinics draining to the CHCs who did not have an RI was 21.3/1 000 births, significantly higher than that in the Umbiflow group 
(11.4/1 000 births) (risk ratio 0.58, 95% confidence interval 0.42 - 0.81). 
Conclusions. The prevalence of AEDF in this low-risk population is ~10 times higher than that previously recorded. Use of the information 
prevented a number of perinatal deaths, most of which would have been macerated stillbirths. Screening a low-risk pregnant population 
using continuous-wave Doppler ultrasound may substantially reduce the prevalence of unexplained stillbirths in SA.
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effect of using the information in managing 
the pregnancies.
Mamelodi township, east of Pretoria, SA, 
has a population of ~410 000 people with 
54 000 households (half living in rooms or 
shacks). About a third of the population is 
unemployed and 20% of households are food 
insecure. There are three healthcare delivery 
sites, Mamelodi Hospital, where the majority 
of births take place, and two community 
health centres (CHCs), Stanza Bopape 
and Dark City, that also conduct births 
and refer to Mamelodi Hospital. There are 
~10 000  births per year in all the facilities. 
Mamelodi Hospital has two obstetricians, 
one of whom (SN) saw all the women referred 
with abnormal Umbiflow tests. The hospital 
can do caesarean deliveries at all times. It 
refers tertiary cases to Steve Biko Academic 
Hospital. The CHCs are run by midwives, as 
are the antenatal clinics draining to them. 
Women with high risk factors are referred to 
the Mamelodi Hospital high-risk antenatal 
clinic for further follow-up. Pregnant 
women are classified as having a low-risk or 
high-risk pregnancy according to the criteria 
of focused antenatal care described by the 
World Health Organization (WHO). [9,10] 
They have five antenatal visits: booking and 
at 20, 26 - 28, 32 - 34 and 38 weeks’ gestation. 
They are referred to the hospital if they have 
not delivered by 41 weeks. HIV-positive 
women are only classified as being at high 
risk if there is a complication associated with 
the HIV infection, e.g. tuberculosis.
Women attending the CHCs between 28 
and 32 weeks’ gestation or with a symphysis-
fundal (SF) measurement of 26 - 30 cm if 
the gestational age was unknown were asked 
to participate in the study and screened for 
placental insufficiency using the Umbiflow. 
In all cases there was a printout of the 
waveforms so that the quality of the Doppler 
examination could be assessed. The accuracy 
of the Umbiflow apparatus was previously 
tested against a commercial unit and the RI 
readings were very similar.[11]
In the cohort analytical study, the out-
come of the population screened with 
Umbiflow testing was compared with that 
in the population that was not screened but 
attended antenatal care in the same areas and 
delivered a singleton baby at ≥28 weeks or a 
baby weighing ≥1 000 g if the gestational age 
was unknown, and received antenatal care at 
either of the CHCs or at the antenatal clinics 
draining to the CHCs.
The Umbiflow RI was classified as either 
low risk or high risk depending on the 
value in relation to the RI graph,[12] using 
a cut-off of the 75th centile. Women with 
a low-risk result were considered normal 
and continued with their routine antenatal 
care. Those with a value >75th centile were 
considered at high risk and referred to the 
high-risk clinic at Mamelodi Hospital. To 
ascertain the false negatives, an author (TH) 
assessed 226 consecutive pregnant women 
from a CHC who had a low-risk Umbiflow 
RI with conventional ultrasound including 
pulsed Doppler.
Fig. 1 illustrates the protocol for managing 
women with an abnormal Umbiflow 
result. At the high-risk clinic, a specialist 
(SN) performed a detailed ultrasound 
examination using a Phillips ultrasound 
with a curvilinear abdominal probe and 
pulsed Doppler. A biophysical profile was 
performed and patients were managed 
based on a set protocol (Fig. 1). Women 
with an abnormal RI but with end-diastolic 
flow were seen weekly for repeat Doppler 
examinations and fortnightly for growth 
scans. Women whose fetus had AEDF 
were admitted; if the fetus was <34 weeks’ 
gestation corticosteroids were given and the 
woman and her fetus were monitored in 
hospital. Delivery was performed when the 
pregnancy reached 34 weeks’ gestation, if the 
cardiotocograph became abnormal, or if the 
mother’s condition deteriorated.
Outcome data were obtained from the 
elec tronic birth register at the various 
delivery sites. Umbiflow measurement was 
performed between 28 and 32 weeks’ gesta-
tion, so most fetuses would have weighed 
>1 000 g at entry to the study. In the 
Umbiflow group, the expected date of 
delivery was recorded, and a search was 
conducted for the woman in the birth 
register from that date. The search included 
looking for delivery prior to the expected 
date to identify women who had delivered 
prematurely. If the woman was not found 
in the register, she was phoned and the 
outcome was recorded; if she could not be 
contacted by telephone after three attempts 
at different times of the day and on different 
days, a home visit was made by the ward-
based outreach teams working with the 
Department of Family Medicine. Only 
after this was the outcome for the woman 
regarded as missing.
SGA was defined as <10th centile 
according to the WHO Fetal Growth 
Charts.[13] Severe pre-eclampsia was defined 
as a blood pressure of 160/110 mmHg on 
two occasions 30 minutes apart and 3+ 
proteinuria according to urine dipsticks or 
symptoms of headache, epigastric pain and 
blurred vision.
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All pregnant women, 28 - 32 weeks' 
gestation or SF 26 - 30 cm
Umbiow
Medium/high risk: AEDF
Mamelodi clinic: growth scans, 
AFI, placenta grading, RI, 
breathing, movement, tone
AEDF
Manage accordingly
Delivery if:
• No growth
• 38 weeks by gestation
• Developing secondary complications
Singleton pregnancy, 
consent
Exclusion: 
High/low gestation, multiple gestation
Low risk: follow up at
 local clinic until delivery
At delivery: gestation, 
Apgar scores, weight, 
possible complications
Admit: steroids, CTG
Weekly visits (AFI/RI),
fortnightly growth scans
WBOT assists with tracing
patients who cannot 
be contacted
Fig. 1. Protocol for managing women with an abnormal Umbiflow result. (SF = symphysis-fundal 
height; AEDF = absent end-diastolic flow; AFI = amniotic fluid index; RI = resistance index; CTG = 
cardiotocograph; WBOT = ward-based outreach team.)
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The project started recruiting women 
for Umbiflow testing on 1 June 2015 and 
data collection of births started then and 
stopped for all births on 31 July 2017. The 
last Umbiflow was performed on 30 April, 
allowing time for the women to give birth. 
Umbiflow tests were done at the two CHCs. 
Funding for 2 years was allocated for the 
study and no sample size calculation was 
performed.
Ethics approval was obtained from the 
University of Pretoria Faculty of Health 
Sciences Ethics Committee (ref. no. 473/ 
2014). Written consent was obtained from 
every woman prior to performing the 
Umbi flow test. The South African Medical 
Research Council, which was one of the 
funders, approved the study protocol.
Results
During the 26-month study period, there 
were 25 918 births at the healthcare delivery 
sites in Mamelodi. After excluding women at 
<28 weeks’ gestation or who gave birth to a 
baby weighing <1 000 g if the gestational age 
was unknown, and those who did not attend 
antenatal care, were <18 years of age or did not 
attend the clinics at or draining to the CHCs, 
15 036 pregnancies were analysed (Fig.  2). 
There were 2 242 pregnancies classified as 
having a low-risk RI (88.3%) and 297 as 
having a high-risk RI (11.7%) with outcomes. 
Thirty-eight fetuses (11.8%) in the high-risk 
group had or developed AEDF (1.5% of the 
population screened with an outcome).
A study within the study was conducted 
to determine the false-negative rate. A 
consecutive sample of 226 pregnant women 
in the Umbiflow group who had a low- 
risk Umbiflow RI were also assessed with 
conventional ultrasound and pulsed Doppler; 
only 3 had a high-risk result, giving a false-
negative rate of 1.3%, and the speci ficity 
was 98.7% in this sub-set. In the study 
group as a whole, 32 women had a high-risk 
Umbiflow RI but a low-risk RI on the pulsed 
Doppler, giving a false-positive rate of 9.0% 
(32/355 Umbiflow high-risk cases). These 
32 patients were referred back to the clinic 
for routine antenatal care. The sensitivity 
was 91.0% for the whole study.
Table 1 sets out the demographics of the 
Umbiflow population. The high-risk group 
had a slightly older age distribution than the 
low-risk group. As expected, the high-risk 
group had more preterm babies and more 
SGA babies, but unexpectedly there were 
fewer HIV-positive women than in the low-
risk group and less severe pre-eclampsia.
The Umbiflow group was similar to 
the cohort analytical study control group 
in maternal age, parity, gestational age at 
delivery, low birth weight and HIV status, 
but had significantly fewer SGA babies and 
less severe pre-eclampsia (Table 2).
The outcomes in the Umbiflow and 
control groups and the impact of active 
management are given in Table 3.
There were more inductions overall in 
the cohort analytical control group than 
in the Umbiflow group, but as expected 
significantly more inductions in the high-
risk Umbiflow group compared with the 
low-risk Umbiflow group in the descriptive 
study. For caesarean deliveries there was 
no overall difference between the cohort 
analytical groups, but a very significant 
difference between the low-risk and high-
risk Umbiflow groups.
Overall the perinatal mortality rate was 
significantly lower in the Umbiflow group 
compared with the control group, in which 
most deaths were macerated stillbirths. There 
were 11 perinatal deaths in the high-risk 
Umbiflow group. Four fetuses had AEDF: 2 
were stillborn after the mother was admitted, 
but the mothers then discharged themselves 
and were lost to follow-up, and 2 died in the 
neonatal period (one was born at 34 weeks 
and died of sepsis on the 8th day, and the 
mother of the other discharged herself and 
was lost to follow-up until she developed 
severe pre-eclampsia and delivered at 36 
weeks; the baby died of sepsis). Seven other 
high-risk babies with end-diastolic flow died 
(one due to abruptio placentae and 3 due to 
congenital abnormalities; the 3 remaining 
women with stillbirths did not arrive at the 
high-risk clinic and were lost to follow-up). 
Ultimately 7 of the 11 women with perinatal 
deaths in the high-risk groups declined 
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Births in Mamelodi township
N=25 918
Excluded:
• Births at <28 weeks or <1 000 g, n=1 866
• Multiple pregnancies, n=286
• Women not attending ANC, n=1 834
• Maternal age <18 years, n=276
Births in Mamelodi
n=21 656
Births from women 
who attended 
clinics draining to 
Stanza Bopape 
and Dark City CHCs
n=12 168
Umbiow group
n=2 868 births
With outcome
n=2 242
With outcome
n=297
• Macerated SB, n=5
• Fresh SB, n=7
• NND, n=6
With EDF
n=259
• Macerated SB, n=4
• Fresh SB, n=3
AEDF
n=38
• Macerated SB, n=2
• NND, n=2
Control group
n= 12 168 births
High risk
n=323
Low risk
n=2 545
Outcome missing
n=26
Outcome missing 
n=303
• Macerated SB, n=136
• Fresh SB, n=65
• NND, n=58
Fig. 2. Flow-chart of cases included in the study. (ANC = antenatal care; SB = stillbirth, NND = neonatal 
death, AEDF = absent end-diastolic flow, EDF = end-diastolic flow.)
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further investigation or treatment and were lost to follow-up. The 
outcomes of all 7 were traced in the birth register or by telephonic 
contact.
Discussion
Main findings
Routine performance of the Umbiflow RI at 28 - 32 weeks’ gestation 
in a low-risk population identified raised Doppler RIs in 11.7% of 
pregnant women. AEDF was found in 1.5% of the Umbiflow group. 
This is a 5 - 10 times higher prevalence of AEDF than recorded in 
other studies screening low-risk or unselected populations.[8] To our 
knowledge, the present study is the first large study using continuous-
wave Doppler ultrasound to screen a pregnant population classified 
as at low risk in a low-income setting. Active management of these 
newly identified high-risk pregnancies improved perinatal outcome 
significantly compared with the control group in which the Umbiflow 
test was not performed.
The Umbiflow has been validated against commercial ultrasound 
machines for the detection of umbilical vessel flow abnormalities.[11] 
The device does not need a trained and experienced sonographer and 
can be operated by trained midwives and nurses. Studies have shown 
that the Umbiflow system can measure the RI of the umbilical blood 
flow accurately when compared with other devices.[11]
Study strengths and limitations
A cut-off of the 75th centile was used for classifying women as at 
high risk.[14] Theoretically 25% of women should have been referred, 
but only 11.3% were. The normal RI curves for SA were developed in 
the 1980s and included the whole population of pregnant women. [12] 
The curves may not be applicable to the current population, as HIV 
infection was rare then and the prevalence of cigarette smoking in 
the population in which the curves were developed was extremely 
high;[15] alternatively, the low proportion of high-risk Umbiflow RIs 
may reflect that the group of women screened in this study were 
truly low risk. Importantly, the women identified as having high-
risk RIs were regarded as having uncomplicated pregnancies at the 
time of the RI and were not identified as having a potential fetal 
problem. Unexplained stillbirth is the most common category listed 
for perinatal death in SA, and approximately two-thirds of these 
fetuses are registered as being macerated, i.e. death is likely to have 
Table 1. Demographic information on Umbiflow populations
Umbiflow
Low risk (N=2 242, 
88.3%), n (%)
High risk (N=297, 
11.7%), n (%)
Total (N=2 539),  
n (%) p-value
Age (years) 0.006
<20 88 (3.9) 6 (2.0) 94 (3.7)
20 - 34 1 757 (78.7) 227 (76.9) 1 984 (78.5)
≥35 387 (17.3) 62 (21.0) 449 (17.8)
Missing data 10 2 12
Parity 0.044
0 712 (31.8) 92 (31.0) 804 (31.4)
1 - 4 1 471 (66.9) 191 (67.3) 1 662 (67.0)
≥5 15 (0.7) 1 (0.4) 16 (0.6)
Missing data 44 13 57
Gestational age (weeks) <0.0001
28 - 33 19 (0.9) 16 (6.5) 35 (1.5)
34 - 37 501 (24.4) 76 (30.8) 577 (25.1)
≥38 1 530 (74.6) 155 (62.8) 1 685 (73.4)
Missing data 198 50 248
LBW (<2 500 g) 181 (8.1) 82 (27.6) 263 (10.4) <0.0001
SGA 362/2 036 (17.8) 83/244 (34.0) 445/2 280 (19.5) 0.022
HIV-positive 530 (24.7) 51 (18.5) 581 (24.0) <0.0001
Missing/unknown HIV status 16 3 19
Severe pre-eclampsia/eclampsia 8 (0.36) 2 (0.67) 13 (0.5) NS
LBW = low birth weight; SGA = small for gestational age; NS = not significant.
Table 2. Comparison between the Umbiflow group and the control group
 Umbiflow (N=2 539) Control group (N=12 168) p-value
Age (years), mean (SD) 28.6 (5.8) 27.7 (6.0) NS
Parity, mean (SD) 1.2 (1.1) 1.3 (1.2) NS
Gestational age (weeks), mean (SD) 38.5 (1.7) 38.8 (2.0) NS
Birth weight (g), mean (SD) 3 068 (521) 3 049 (540) NS
LBW (<2 500 g), n (%) 263 (10.4) 1 464 (12.0) NS
SGA, n (%) 445/2 280 (19.5) 2 905/10 886 (26.7) <0.0001
HIV-positive, n (%) 581 (24.0) 2 973 (24.4) NS
Severe pre-eclampsia/eclampsia, n (%) 14 (0.5) 136 (1.1) <0.001
SD = standard deviation; NS = not significant; LBW = low birth weight; SGA = small for gestational age.
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occurred antenatally.[6] A significant proportion of these stillbirths 
were SGA. [16] The biggest impact of the Umbiflow screening was in 
preventing macerated/antenatal stillbirths. This finding was to be 
expected, as raised RIs are associated with placental insufficiency and 
growth restriction.[5]
Screening with the Umbiflow was performed between 28 and 
32  weeks’ gestation, as the pregnancy could be managed actively if 
an abnormality was detected, with an expectation of a good chance 
of neonatal survival with the current facilities at Mamelodi Hospital. 
Further, the number of SGA stillbirths is highest in the gestational age 
group 32 - 37 weeks.[16] The peak of stillbirths also occurs between 32 
and 37 weeks’ gestation, indicating that the potential for preventing 
stillbirths is considerable.
Once detected, the women with a high-risk RI were managed 
actively, and mortality rates for the whole Umbiflow group were 
significantly lower than for the comparison group of women who did 
not have an Umbiflow RI. This decrease in mortality was not due to an 
increased intervention rate, as the induction and caesarean delivery 
rates were similar. However, the cohort analytical control group fell 
into a higher risk category than the Umbiflow group, as evidenced 
by the increased prevalence of SGA babies and pre-eclampsia. The 
increase in pre-eclampsia and SGA babies in the control group may 
explain the higher mortality rates. A randomised trial would need to 
be performed to create a true control group.
Fetuses with AEDF not managed actively have a high morta-
lity. [17,18] In this study the fetuses with AEDF were actively managed 
according to protocol, provided the mother agreed. Most of these 
fetuses survived, but there were two stillbirths in women who 
declined further treatment and were lost to follow-up, two neonatal 
deaths due to a nosocomial infection, and one neonatal death in a 
woman who declined treatment until she was admitted with severe 
pre-eclampsia. These unfortunate cases form a natural experiment 
and indicate the severe prognosis of AEDF.
Despite extensive efforts being made to trace the women, 11.5% of 
pregnancies in the Umbiflow group were without outcome data (8.0% 
in the high-risk group, among which there was one case of AEDF). 
However, this figure is acceptable given that the study was done in a 
low-income setting with a very mobile population.
Interpretation
Any implementation of an Umbiflow screening programme will have 
to ensure that there is an effective system of communication and 
follow-up as well as the necessary high-care resources. If the seven 
women described above had agreed to the management protocol, 
the deaths of their babies might have been prevented. The high-risk 
Umbiflow clinic averaged about 10 - 15 cases per week, and this 
put pressure on the resources available at Mamelodi Hospital. The 
neonatal unit was also put under increased pressure with an increased 
number of small babies being delivered. However, despite the high 
caesarean delivery rate in the high-risk Umbiflow group, there was 
no overall increase in caesarean deliveries when comparing the 
caesarean delivery rate between all the women who had an Umbiflow 
test and those women who did not have the test (control group), so in 
the context of this study Umbiflow testing did not put extra pressure 
on these resources.
Use of the Umbiflow was simple for the research nurses to learn, 
only 2 weeks being needed to master the technique, and with a 
printout of the result the quality of the recordings could be checked. 
The false-negative rate was 1.3% and the false-positive rate 9.0% 
compared with pulsed Doppler, indicating that the Umbiflow RI is 
reliable. It can easily be used to screen a large population and requires 
minimal resources; however, significant resources would be required 
for women with an abnormal Umbiflow RI.
Several new questions arise as a result of this study. Is the 
prevalence of AEDF of the umbilical artery the same in other low-
income settings? Why was the prevalence of AEDF so much higher 
than in high-income settings? Can a more effective cut-off for referral 
be determined? What will be the most effective methods to scale up 
this screening, and at what cost?
The WHO states in its new antenatal care guidelines:[19] ‘Accurate 
low-cost methods for detecting abnormal growth are desirable 
because ultrasound, the most accurate screening tool, is resource-
intensive and not widely available in LMICs.’ At present the only 
way to determine the fetal growth rate at primary care level in SA 
is by measuring the SF height. A recent study of two-stage routine 
ultrasound scanning in LMICs found no effect on stillbirths or 
neonatal mortality or an increase in antenatal attendance,[20] seriously 
calling into question the role of routine ultrasound in preventing 
perinatal deaths. Screening using continuous-wave Doppler 
ultrasound may be much more useful than conventional ultrasound 
and SF measurements in detecting fetuses at risk of stillbirth. The 
prevalence of AEDF in other LMIC settings needs to be confirmed, 
and a randomised trial will need to be performed to confirm its effect 
on mortality
Conclusions
The prevalence of AEDF of the umbilical artery in a low-risk pregnant 
population was ~10 times higher in the Mamelodi population than 
previously recorded in high-income countries. Use of the Umbiflow 
findings led to a reduction in the perinatal mortality rate, the 
Table 3. Outcome and impact: Comparison between the Umbiflow group and the control group
Complications
Umbiflow
Control (N=12 168) p-valueLow risk (N=2 242) High risk (N=297) Total (N=2 539)
Induction, n (%)* 15 (0.7) 11 (3.7) 26 (1.0) 238 (2.0) 0.003
Caesarean delivery, n (%)** 372 (20.2) 142 (50.9) 514 (24.3) 3 048 (25.0) 0.61
Mortality† RR (95% CI)
Total SBs, n (SBR/1 000 births) 12 (5.3) 9 (30.3) 21 (8.3) 201 (16.5) 0.55 (0.37 - 0.80)
Macerated SBs, n (MSBR/1 000 births) 5 (2.2) 6 (20.2) 11 (4.3) 136 (11.2) 0.40 (0.23 - 0.68)
Fresh SBs, n (FSBR/1 000 births) 7 (3.1) 3 (10.1) 10 (4.0) 65 (5.3) 0.84 (0.49 - 1.44)
NNDs, n (NNDR/1 000 live births) 6 (2.7) 2 (6.9) 8 (3.2) 58 (4.8) 0.72 (0.38 - 1.32)
Perinatal deaths, (PNMR/1 000 births) 18 (8.0) 11 (37.0) 29 (11.4) 259 (21.3) 0.58 (0.42 - 0.81)
RR = risk ratio; CI = confidence interval; SBs = stillbirths; SBR = stillbirth rate; MSBR = macerated stillbirth rate; FSBR = fresh stillbirth rate; NNDs = neonatal deaths;  
NNDR = neonatal death rate; PNMR = perinatal mortality rate.
*Low risk v. high risk p<0.0001, **Low risk v. high risk p<0.0001.
†Includes 3 stillbirths with congenital abnormality; if these are excluded the SBR would be 7.1/1 000 births and the PNMR 10.3/1 000 births.
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reduction being greatest in macerated stillbirths. Umbiflow screening 
is potentially an effective way of screening all women for abnormal 
Doppler flow velocities to reduce unexpected fetal death.
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